1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPN CTRPv2 pan-cancer AAC 0.28 7e-09
mRNA ZBED4 CTRPv2 pan-cancer AAC 0.28 2e-12
mRNA GPC2 CTRPv2 pan-cancer AAC 0.26 2e-09
mRNA RCC2 CTRPv2 pan-cancer AAC 0.26 9e-11
mRNA LDOC1L CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA CBX2 CTRPv2 pan-cancer AAC 0.24 6e-10
mRNA SUGP2 CTRPv2 pan-cancer AAC 0.24 3e-09
mRNA KLHL23 CTRPv2 pan-cancer AAC 0.24 3e-10
mRNA MYB CTRPv2 pan-cancer AAC 0.24 5e-09
mRNA ZNF445 CTRPv2 pan-cancer AAC 0.24 1e-09
Download CSV